{
  "id": "fe7a82c593caca99",
  "title": "Buyout Wave Seen Among Japan Drugmakers After Hisamitsu Deal",
  "description": "Hisamitsu Pharmaceutical Co.\u2019s \u00a5457 billion ($2.9 billion) plan to go private is being seen as a prime example of a flight from public markets among Japan\u2019s drugmakers, with analysts expecting more to follow.",
  "content": "Hisamitsu Pharmaceutical Co.\u2019s \u00a5457 billion ($2.9 billion) plan to go private is being seen as a prime example of a flight from public markets among Japan\u2019s drugmakers, with analysts expecting more to follow.",
  "source": "Bloomberg Markets",
  "source_url": "https://www.bloomberg.com/news/articles/2026-01-07/buyout-wave-seen-among-japan-drugmakers-after-hisamitsu-deal",
  "published_at": "2026-01-07T22:00:00+00:00",
  "fetched_at": "2026-01-08T00:23:56.998868+00:00",
  "category": "macroeconomics_finance",
  "subcategory": null,
  "keywords": [
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "Buyout Wave Seen Among Japan Drugmakers After Hisamitsu Deal",
    "description": "Hisamitsu Pharmaceutical Co.\u2019s \u00a5457 billion ($2.9 billion) plan to go private is being seen as a prime example of a flight from public markets among Japan\u2019s drugmakers, with analysts expecting more to follow.",
    "url": "https://www.bloomberg.com/news/articles/2026-01-07/buyout-wave-seen-among-japan-drugmakers-after-hisamitsu-deal",
    "published": "2026-01-07T22:00:00+00:00",
    "source": "Bloomberg Markets"
  }
}